Clinical Trial Update: Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effectiveness and tolerability of lidocaine 5% spray for lifelong premature ejaculation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• lidocaine 5% spray (lidocaine)

Snippet

Sponsor: Sohag University | Conditions: Lidocaine Spray | Phase 2 | Status: COMPLETED